Avinger to price its IPO of 4,615,384 shares between $12.00 and $14.00

Company to sell stock through bookrunners Canaccord Genuity and Cowen

By Devika Patel

Knoxville, Tenn., Jan. 20 – Avinger Inc. will sell 4,615,384 common shares in its initial public offering with a 30-day greenshoe option of 692,307 additional shares, according to a Form S-1/A filed Friday with the Securities and Exchange Commission. The deal was announced Dec. 31. The company has registered up to $74.31 million of stock.

The shares will be sold at a price expected to fall between $12.00 and $14.00 per share.

Canaccord Genuity and Cowen and Co. are the bookrunning managers. Oppenheimer & Co., BTIG and Stephens Inc. are the co-managers.

Proceeds will be used for working capital and other general corporate purposes.

The medical device company is based in Redwood City, Calif. The company’s expects its shares will trade on the Nasdaq under the symbol “AVGR.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.